Integra Lifesciences Holdings (IART) Cash from Operations Growth (3y) (2012 - 2026)
Integra Lifesciences Holdings (IART) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 27.41% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 22.38% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 30.85% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 168.71% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 12.26% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 65.19% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 43.79% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 9.30% |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn | -6.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.92% |
| Mar 31, 2026 | -27.90% |
| Dec 31, 2025 | -48.27% |
| Sep 30, 2025 | -15.71% |
| Jun 30, 2025 | -48.81% |
| Mar 31, 2025 | -31.11% |
| Dec 31, 2024 | -9.86% |
| Sep 30, 2024 | -35.24% |
| Jun 30, 2024 | -23.79% |
| Mar 31, 2024 | -38.90% |
| Dec 31, 2023 | -9.88% |
| Sep 30, 2023 | -27.29% |
| Jun 30, 2023 | -5.13% |
| Mar 31, 2023 | 7.91% |
| Dec 31, 2022 | -1.46% |
| Sep 30, 2022 | 2.07% |
| Jun 30, 2022 | 11.06% |
| Mar 31, 2022 | 14.57% |
| Dec 31, 2021 | 17.52% |
| Sep 30, 2021 | 1.46% |